Superiority of clinical American Joint Committee on Cancer T classification for perihilar cholangiocarcinoma

Author(s):  
Mihoko Yamada ◽  
Takashi Mizuno ◽  
Junpei Yamaguchi ◽  
Yukihiro Yokoyama ◽  
Tsuyoshi Igami ◽  
...  
2020 ◽  
Vol 52 (3) ◽  
pp. 886-895
Author(s):  
Jong Woo Lee ◽  
Jae Hoon Lee ◽  
Yejong Park ◽  
Woohyung Lee ◽  
Jaewoo Kwon ◽  
...  

PurposeThis study was conducted to evaluate the prognostic values of the 7th and 8th American Joint Committee on Cancer (AJCC) staging systems for patients with resected perihilar cholangiocarcinoma (PHCC).Materials and MethodsA total of 348 patients who underwent major hepatectomy for PHCC between 2008 and 2015 were identified from a single center. Overall survival (OS) was estimated using the Kaplan-Meier method and compared across stage groups with the log-rank test. The concordance index was used to evaluate the prognostic predictability of the 8th AJCC staging system compared with that of the 7th.ResultsIn the 8th edition, the stratification of each group of T classification improved compared to that in the 7th, as the survival rate of T4 decreased (T2, 31.2%; T3, 13.9%; T4, 15.1%; T1- T2, p=0.260; T2-T3, p=0.001; T3-T4, p=0.996). Both editions showed significant survival differences between each N category, except between N1 and N2 (p=0.063) in 7th edition. Differences of point estimates between the 8th and 7th T and N classification and overall stages were +0.028, +0.006, and +0.039, respectively (T, p=0.005; N, p=0.115; overall stage, p=0.005). In multivariable analysis, posthepatectomy liver failure, T category, N category, distant metastasis, histologic differentiation, intraoperative transfusion, and resection margin status were associated with OS.ConclusionThe prognostic predictability of 8th AJCC staging for PHCC improved slightly, with statistical significance, compared to the 7th edition, but its overall performance is still unsatisfactory.


HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S182-S183
Author(s):  
M. Gaspersz ◽  
S. Buettner ◽  
J. van Vugt ◽  
J. de Jonge ◽  
W. Polak ◽  
...  

Surgery ◽  
2009 ◽  
Vol 146 (2) ◽  
pp. 250-257 ◽  
Author(s):  
Seung-Mo Hong ◽  
Timothy M. Pawlik ◽  
HyungJun Cho ◽  
Bhuvnesh Aggarwal ◽  
Michael Goggins ◽  
...  

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S325
Author(s):  
Jong Woo Lee ◽  
Jae Hoon Lee ◽  
Yejong Park ◽  
Jaewoo Kwon ◽  
Woohyung Lee ◽  
...  

HPB ◽  
2014 ◽  
Vol 16 (12) ◽  
pp. 1074-1082 ◽  
Author(s):  
Bas Groot Koerkamp ◽  
Jimme K. Wiggers ◽  
Peter J. Allen ◽  
Olivier R.C. Busch ◽  
Michael I. D'Angelica ◽  
...  

Surgery ◽  
2018 ◽  
Vol 164 (2) ◽  
pp. 244-250 ◽  
Author(s):  
Andrea Ruzzenente ◽  
Fabio Bagante ◽  
Francesco Ardito ◽  
Tommaso Campagnaro ◽  
Iole Scoleri ◽  
...  

2018 ◽  
Vol 103 (6) ◽  
pp. 2199-2206 ◽  
Author(s):  
Bryan Tran ◽  
David Roshan ◽  
Earl Abraham ◽  
Laura Wang ◽  
Natalia Garibotto ◽  
...  

Abstract Background The American Joint Committee on Cancer (AJCC) removed microscopic extrathyroidal extension (ETE) from the 8th edition T staging for papillary thyroid cancer (PTC) based on increasing evidence that it is not an independent prognostic factor. Objectives We compared the prognostic performance of AJCC 7th (pT7) and 8th (pT8) edition T stage systems, particularly in patients ≥55 years old without macroscopic ETE or distant metastases in whom T classification affects AJCC Tumor Node Metastasis (TNM) stage. Method A retrospective analysis of disease-free survival (DFS) in 577 patients with PTC comparing pT8 vs pT7 using the Akaike information criterion (AIC), Harrell’s C-index, and Proportion of Variation Explained (PVE). Results Of 105 patients with AJCC7 T3 disease, 74 were down-staged. Overall, the prognostic performance of pT7 and pT8 was similar. However, in patients ≥55 years old without macroscopic ETE or distant metastases, pT8 was inferior to pT7 on the basis of higher AIC, lower C-index (0.67 vs 0.76), and lower PVE (30% vs 45%). In this subset, microscopic ETE was associated with multiple other adverse prognostic features and reduced DFS (hazard ratio, 2.8; 95% confidence interval, 1.5 to 5.2; P = 0.002), irrespective of tumor size. Discussion In our cohort, pT8 was inferior to pT7 in patients ≥55 years old without macroscopic ETE or distant metastases in whom T classification affects TNM stage. Microscopic ETE was strongly associated with other adverse prognostic factors and reduced DFS in this patient subgroup and may be an effective surrogate for disease biology in PTC, irrespective of whether it is an independent prognostic factor.


Cancer ◽  
2006 ◽  
Vol 106 (9) ◽  
pp. 1950-1957 ◽  
Author(s):  
Joshua A. Asper ◽  
William H. Morrison ◽  
David I. Rosenthal ◽  
Anesa Ahamad ◽  
K. Kian Ang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document